Previous 10 | Next 10 |
Dan Loeb's 13F portfolio value increased from $14.83B to $17.08B this quarter. The number of positions increased from 125 to 126. Third Point added SoFi Technologies and increased Intel Corp. and Cano Health during the quarter. They also dropped IAA Inc. and reduced Charter Communicat...
Glenview Capital Management’s 13F portfolio value increased marginally from $5.90B to $5.96B this quarter. The number of positions increased from 63 to 64. They increased ViacomCBS and Global Payments while reducing Cigna, DXC Technology, Takeda Pharmaceuticals, and HCA Healthc...
Harding Loevner is an investment manager that invests primarily in publicly traded global equities. We were founded in 1989 by former managers for the Rockefeller family. Harding Loevner is a Delaware limited partnership. We operate independently of Affiliated Managers Group. The Glob...
IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, today announced a transformative collaboration with NRx Pharmaceuticals (NRx) (Nasdaq: NRXP). NRx is a company dedicated to creat...
IQVIA™ (NYSE: IQV) announces its strategic collaboration with HealthCore, Inc., a leading real world research organization in the United States, to advance real world evidence (RWE) studies with increased quality and efficiency. RWE studies incorporate innovative scientific metho...
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), announced today that Ron Bruehlman, executive vice president and chief financial officer, will participate in a virtual fireside chat at the Baird 2021 Global Healthcare Conference on Tuesday, September 14, 2021 at 12:15 p.m. EDT. ...
IQVIA ™ (NYSE:IQV), a global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today announced it has added new AI-powered technologies to enhance its existing Medical Information (MI) Contact Center services. ...
IQVIA Holdings Inc. (NYSE:IQV) traded today at a new 52-week high of $256.34. This new high was reached on below average trading volume as 174,000 shares traded hands, while the average 30-day volume is approximately 791,000 shares. IQVIA is the result of the 2016 merger of Quintiles, a ...
The fund is a long-only investment manager. We do not use leverage and we do not short. Since we only invest when we have high conviction, we manage a concentrated portfolio. The L1 Capital International Fund’s performance during the June 2021 quarter was strong, returning 11.5...
Third Point is an SEC-registered investment adviser based in New York. The firm was founded in 1995 by Daniel S. Loeb, who serves as Chief Executive Officer. Third Point focuses on event-driven, value-oriented investing. During the Second Quarter, Third Point returned +3.7% in the Off...
News, Short Squeeze, Breakout and More Instantly...
2024-07-23 10:00:13 ET Jailendra Singh from Truist Financial issued a price target of $300.00 for IQV on 2024-07-23 09:26:00. The adjusted price target was set to $300.00. At the time of the announcement, IQV was trading at $240.265. The overall price target consensus is...
2024-07-23 10:00:11 ET Elizabeth Anderson from Evercore ISI issued a price target of $270.00 for IQV on 2024-07-23 08:59:00. The adjusted price target was set to $270.00. At the time of the announcement, IQV was trading at $239.5. The overall price target consensus is at...
2024-07-23 07:00:06 ET Luke Sergott from Barclays issued a price target of $275.00 for IQV on 2024-07-23 05:25:00. The adjusted price target was set to $275.00. At the time of the announcement, IQV was trading at $245.23. The overall price target consensus is at $273.93 ...